Understanding The Development Of Human Bladder Cancer By Using A Whole Organ Genomic Mapping Strategy

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Source : http://www.nature.com/labinvest/journal/v88/n7/fig_tab/labinvest200827f6.html?message=remove

Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy
Evolution may explain why baby comes early
Cancer therapy: A role for MAPK inhibitors combined with mTORC1 inhibitors
A chimp-pig hybrid origin for humans?
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
ENCODE: the rough guide to the human genome
Combined physical and genetic map finds cancer's 'ignition key'
Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy